- Home
- PMF vs INMB Comparison
PMF vs INMB Comparison
Compare PMF & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMF
- INMB
- Stock Information
- Founded
- PMF 2001
- INMB 2015
- Country
- PMF United States
- INMB United States
- Employees
- PMF N/A
- INMB N/A
- Industry
- PMF Finance/Investors Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- PMF Finance
- INMB Health Care
- Exchange
- PMF Nasdaq
- INMB Nasdaq
- Market Cap
- PMF 234.4M
- INMB 203.5M
- IPO Year
- PMF N/A
- INMB 2019
- Fundamental
- Price
- PMF $8.98
- INMB $8.04
- Analyst Decision
- PMF
- INMB Strong Buy
- Analyst Count
- PMF 0
- INMB 3
- Target Price
- PMF N/A
- INMB $24.33
- AVG Volume (30 Days)
- PMF 61.3K
- INMB 253.4K
- Earning Date
- PMF 01-01-0001
- INMB 05-08-2025
- Dividend Yield
- PMF 5.36%
- INMB N/A
- EPS Growth
- PMF N/A
- INMB N/A
- EPS
- PMF N/A
- INMB N/A
- Revenue
- PMF N/A
- INMB $42,000.00
- Revenue This Year
- PMF N/A
- INMB N/A
- Revenue Next Year
- PMF N/A
- INMB N/A
- P/E Ratio
- PMF N/A
- INMB N/A
- Revenue Growth
- PMF N/A
- INMB N/A
- 52 Week Low
- PMF $7.69
- INMB $4.32
- 52 Week High
- PMF $10.56
- INMB $12.72
- Technical
- Relative Strength Index (RSI)
- PMF 39.32
- INMB 48.26
- Support Level
- PMF $9.01
- INMB $7.79
- Resistance Level
- PMF $9.42
- INMB $8.35
- Average True Range (ATR)
- PMF 0.14
- INMB 0.59
- MACD
- PMF -0.03
- INMB -0.05
- Stochastic Oscillator
- PMF 2.22
- INMB 48.05
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.